EN
HI
Panacea Biotec share price chart
Panacea Biotec Share Key Metrics
Volume
1.27 L
Market Cap
2518.02 CR
LTQ@LTP
22@411.10
ATP
409.45
Var Margin
27.3 %
Circuit Range
370-452.2
Delivery %
54.84 %
Value
5.20 CR
ASM/GSM
No
Market Lot
1
Summary
PANACEABIO stock price is ₹411.1 as of 23 Aug, 2026. The stock intraday movement has stayed between ₹403.55 and ₹420.40, while Panacea Biotec share price 52 week high low is ₹292.40 & ₹647.00.
In terms of trading activity, PANACEABIO share price has recorded a volume of 1,26,999 shares. The Panacea Biotec has a market cap of ₹61250746. The stock’s Average Traded Price (ATP) stands at ₹409.45, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 22 @ ₹411.10.
The Panacea Biotec upper circuit limit is ₹452.20 & The Panacea Biotec lower circuit limit is ₹370.00, with a Value of ₹5.20 CR. The Delivery Percentage for the day is 54.84%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Panacea Biotec Fundamentals
P/E Ratio
0
P/B Ratio
3
Div. Yield
0
Sector P/E
68.51
Sector P/B
3.35
Sec. Div. Yield
0.51
Panacea Biotec Resistance and Support
Pivot 413.23
Resistance
First Resistance
420.76
Second Resistance
427.88
Third Resistance
435.41
Support
First Support
406.11
Second Support
398.58
Third Support
391.46
Panacea Biotec Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 21 2026 | 413.65 | 411.1 | -0.61% | 420.4 | 403.55 |
| Thu Aug 20 2026 | 409.04 | 413.64 | 2.73% | 420.35 | 405.7 |
| Wed Aug 19 2026 | 408 | 402.64 | -0.79% | 416.7 | 401.29 |
Panacea Biotec Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-05-30 | Audited Results & Dividend |
| 2026-05-29 | Audited Results & Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Panacea Biotec News
Panacea Biotec Ltd - 531349 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026
Panacea Biotec's Board approved Q1 FY27 financial results, with consolidated net profit of ₹2.20 crore, a notable improvement from a ₹7.16 crore loss YoY. The 42nd AGM is scheduled for September 29, 2026.
Aug 13 2026 18:46:56
Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Panacea Biotec secured a Letter of Award from UNICEF for the supply of bivalent Oral Polio Vaccine (bOPV) worth US$8.205 million (~Rs.78.24 crore). This order is for Calendar Year 2028 and is part of a previously announced Long-Term Agreement.
Aug 05 2026 09:39:07
Panacea Biotec Management
| Name | Position |
|---|---|
| Ankit Jain | Company Secretary and Compliance Officer |
| Rajesh Jain | Chairman & Managing Director |
Panacea Biotec Similar Stocks
Ind-Swift Laboratories Ltd.
329.59
-3.92 (1.18%)
Dishman Carbogen Amcis Ltd.
173.54
1.13 (0.66%)
Beta Drugs Ltd.
2327.70
32.70 (1.42%)
Solara Active Pharma Sciences Ltd.
616.90
-23.10 (3.61%)
Hikal Ltd.
215.61
3.35 (1.58%)
Dr Agarwals Eye Hospital Ltd.
5395.00
88.00 (1.66%)
Sai Parenteral's Ltd.
540.85
-2.55 (0.47%)
Venus Remedies Ltd.
1738.10
-27.50 (1.56%)
Panacea Biotec FAQs
The Buying Price of Panacea Biotec share is 411.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Panacea Biotec stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Panacea Biotec, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Panacea Biotec shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Panacea Biotec shares is 3. Useful to assess the stock's value relative to its book value.
To assess Panacea Biotec’s valuation compare Sector P/E, P/B which are 68.51 & 3.35 with sector averages, along with growth rates and financial metrics.
The Market Cap of Panacea Biotec is 2518.02 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Panacea Biotec share price is 647.00 & 292.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Panacea Biotec belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in PANACEABIO
Or Download Choice FinX App
Invest in PANACEABIO
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade